Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes - The Diabetes Outcomes in Veterans Study (DOVES)

被引:14
作者
Murata, GH
Duckworth, WC
Shah, JH
Wendel, CS
Hoffman, RM
机构
[1] New Mexico VA Hlth Care Syst, Albuquerque, NM 87108 USA
[2] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
[3] Carl T Hayden VA Med Ctr, Phoenix, AZ USA
[4] Univ Arizona, Coll Med, Tucson, AZ USA
关键词
diabetes mellitus; non-insulin-dependent; hypoglycemia; blood glucose monitoring; blood glucose;
D O I
10.1016/j.diabres.2003.11.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify clinical factors that affect hypoglycemia perception in type 2 diabetes. Methods: Prospective observational study of 344 insulin-treated subjects randomly selected from pharmacy records at three large medical centers. At entry, subjects underwent an extensive psychological evaluation and then monitored their blood glucoses in their usual fashion for up to 52 weeks using a glucose meter capable of storing 1000 readings. For blood glucoses less than or equal to3.33 mmol/l (60 mg/dl), subjects recorded the severity of symptoms in a log book. Symptoms were scored '0' if they were asymptomatic, '1' for symptoms that were mild-to-moderate, and '2' if the subject had a diminished level of consciousness or required the assistance of others. A mean blood glucose and mean symptom score were calculated for all hypoglycemic episodes detected by each patient. Results: One hundred seventy-six subjects (51.2%) had a median of 4.5 hypoglycemic events during 42.5 +/- 8.0 weeks of follow-up. The mean hypoglycemic blood glucoses and mean symptom scores were modestly correlated (r = 0.153; P = 0.043). After adjusting for blood glucose, symptom scores were lower in the elderly and higher in subjects with higher diabetes knowledge scores, microvascular complications, and higher entry hemoglobin A1c. Multiple linear regression showed that the latter three factors were independently predictive of higher symptoms. Conclusions: Conventional clinical data may be useful in identifying patients with poor hypoglycemia perception. Patients with better long- and short-term glycemic control are at higher risk and may benefit from instruction on all aspects of hypoglycemia. Published by Elsevier Ireland Ltd.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 20 条
[1]   VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL [J].
ABRAIRA, C ;
COLWELL, JA ;
NUTTALL, FQ ;
SAWIN, CT ;
NAGEL, NJ ;
COMSTOCK, JP ;
EMANUELE, NV ;
LEVIN, SR ;
HENDERSON, W ;
LEE, HS .
DIABETES CARE, 1995, 18 (08) :1113-1123
[2]   Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms [J].
Burge, MR ;
Sobhy, TA ;
Qualls, CR ;
Schade, DS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5471-5478
[3]   LONG-TERM FOLLOW-UP EVALUATION AT BLOOD-GLUCOSE AWARENESS TRAINING [J].
COX, DJ ;
GONDERFREDERICK, L ;
JULIAN, DM ;
CLARKE, W .
DIABETES CARE, 1994, 17 (01) :1-5
[4]   Blood glucose awareness training (BGAT-2) - Long-term benefits [J].
Cox, DJ ;
Gonder-Frederick, L ;
Polonsky, W ;
Schlundt, D ;
Kovatchev, B ;
Clarke, W .
DIABETES CARE, 2001, 24 (04) :637-642
[5]   Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes [J].
Cryer, PE .
DIABETOLOGIA, 2002, 45 (07) :937-948
[6]   The reliability and validity of a brief diabetes knowledge test [J].
Fitzgerald, JT ;
Funnell, MM ;
Hess, GE ;
Barr, PA ;
Anderson, RM ;
Hiss, RG ;
Davis, WK .
DIABETES CARE, 1998, 21 (05) :706-710
[7]   Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes [J].
Harris, MI .
DIABETES CARE, 2001, 24 (06) :979-982
[8]   Evaluatin once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes [J].
Hoffman, RM ;
Shah, JH ;
Wendel, CS ;
Duckworth, WC ;
Adam, KD ;
Bokhari, SU ;
Dalton, C ;
Murata, GH .
DIABETES CARE, 2002, 25 (10) :1744-1748
[9]  
Jaap AJ, 1998, DIABETIC MED, V15, P398, DOI 10.1002/(SICI)1096-9136(199805)15:5<398::AID-DIA595>3.0.CO
[10]  
2-B